Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0245 per EA under NDC 00378395005. Its NADAC has been published 656 times since Dec 5, 2013.
Strength
10 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378395005
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091226On Market Since
9/19/2013
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 656 times since Dec 5, 2013, and over the history we have for it it has declined 81.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0245 per EA |
|---|---|
| All-time high | $0.1351 (Dec 11, 2013) |
| All-time low | $0.0224 (Nov 20, 2024) |
| 52-week high | $0.0277 |
| 52-week low | $0.0245 |
| Median price | $0.0545 |
| Average price | $0.0612 |
| Largest weekly change | -25.9% (Apr 17, 2024) |
| Weeks tracked | 656 |
| Tracking since | Dec 5, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0245 per EA (NDC 00378395005), effective Jun 24, 2026.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has declined 81.8%. It has been tracked across 656 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since Dec 5, 2013, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0224 (Nov 20, 2024) to a high of $0.1351 (Dec 11, 2013), with a median of $0.0545 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ATORVASTATIN 10 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 00378395005) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification